Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pet Meds and Supplements Market Growth 2022-2028

  • LP 4935126
  • 122 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pet Meds and Supplements will have significant change from previous year. According to our (LP Information) latest study, the global Pet Meds and Supplements market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Meds and Supplements market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Pet Meds and Supplements market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Meds and Supplements market, reaching US$ million by the year 2028. As for the Europe Pet Meds and Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Pet Meds and Supplements players cover Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, and Dechra Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Meds and Supplements market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

External Use

Oral Use

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Dogs

Cats

Rabbit

Bird

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Boehringer Ingelheim

Ceva Sante Animale

Bimeda Animal Health

Dechra Pharmaceuticals

Zoetis

Merck

Elanco

Bayer

Boehringer

Novartis

Virbac

Ceva

Vetoquinol

Nexvet

Aratana Therapeutics

Kindred Biosciences

Ambrx

Entest Biomedical

Taconic Biosciences

Dechra Veterinary Products

Ouro Fino Saude

Norbrook

Frontline

Zesty Paws

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pet Meds and Supplements Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pet Meds and Supplements by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pet Meds and Supplements by Country/Region, 2017, 2022 & 2028

2.2 Pet Meds and Supplements Segment by Type

2.2.1 External Use

2.2.2 Oral Use

2.3 Pet Meds and Supplements Sales by Type

2.3.1 Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)

2.3.2 Global Pet Meds and Supplements Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pet Meds and Supplements Sale Price by Type (2017-2022)

2.4 Pet Meds and Supplements Segment by Application

2.4.1 Dogs

2.4.2 Cats

2.4.3 Rabbit

2.4.4 Bird

2.4.5 Other

2.5 Pet Meds and Supplements Sales by Application

2.5.1 Global Pet Meds and Supplements Sale Market Share by Application (2017-2022)

2.5.2 Global Pet Meds and Supplements Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pet Meds and Supplements Sale Price by Application (2017-2022)

3 Global Pet Meds and Supplements by Company

3.1 Global Pet Meds and Supplements Breakdown Data by Company

3.1.1 Global Pet Meds and Supplements Annual Sales by Company (2020-2022)

3.1.2 Global Pet Meds and Supplements Sales Market Share by Company (2020-2022)

3.2 Global Pet Meds and Supplements Annual Revenue by Company (2020-2022)

3.2.1 Global Pet Meds and Supplements Revenue by Company (2020-2022)

3.2.2 Global Pet Meds and Supplements Revenue Market Share by Company (2020-2022)

3.3 Global Pet Meds and Supplements Sale Price by Company

3.4 Key Manufacturers Pet Meds and Supplements Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pet Meds and Supplements Product Location Distribution

3.4.2 Players Pet Meds and Supplements Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pet Meds and Supplements by Geographic Region

4.1 World Historic Pet Meds and Supplements Market Size by Geographic Region (2017-2022)

4.1.1 Global Pet Meds and Supplements Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pet Meds and Supplements Annual Revenue by Geographic Region

4.2 World Historic Pet Meds and Supplements Market Size by Country/Region (2017-2022)

4.2.1 Global Pet Meds and Supplements Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pet Meds and Supplements Annual Revenue by Country/Region

4.3 Americas Pet Meds and Supplements Sales Growth

4.4 APAC Pet Meds and Supplements Sales Growth

4.5 Europe Pet Meds and Supplements Sales Growth

4.6 Middle East & Africa Pet Meds and Supplements Sales Growth

5 Americas

5.1 Americas Pet Meds and Supplements Sales by Country

5.1.1 Americas Pet Meds and Supplements Sales by Country (2017-2022)

5.1.2 Americas Pet Meds and Supplements Revenue by Country (2017-2022)

5.2 Americas Pet Meds and Supplements Sales by Type

5.3 Americas Pet Meds and Supplements Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pet Meds and Supplements Sales by Region

6.1.1 APAC Pet Meds and Supplements Sales by Region (2017-2022)

6.1.2 APAC Pet Meds and Supplements Revenue by Region (2017-2022)

6.2 APAC Pet Meds and Supplements Sales by Type

6.3 APAC Pet Meds and Supplements Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pet Meds and Supplements by Country

7.1.1 Europe Pet Meds and Supplements Sales by Country (2017-2022)

7.1.2 Europe Pet Meds and Supplements Revenue by Country (2017-2022)

7.2 Europe Pet Meds and Supplements Sales by Type

7.3 Europe Pet Meds and Supplements Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pet Meds and Supplements by Country

8.1.1 Middle East & Africa Pet Meds and Supplements Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pet Meds and Supplements Revenue by Country (2017-2022)

8.2 Middle East & Africa Pet Meds and Supplements Sales by Type

8.3 Middle East & Africa Pet Meds and Supplements Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pet Meds and Supplements

10.3 Manufacturing Process Analysis of Pet Meds and Supplements

10.4 Industry Chain Structure of Pet Meds and Supplements

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pet Meds and Supplements Distributors

11.3 Pet Meds and Supplements Customer

12 World Forecast Review for Pet Meds and Supplements by Geographic Region

12.1 Global Pet Meds and Supplements Market Size Forecast by Region

12.1.1 Global Pet Meds and Supplements Forecast by Region (2023-2028)

12.1.2 Global Pet Meds and Supplements Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pet Meds and Supplements Forecast by Type

12.7 Global Pet Meds and Supplements Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Pet Meds and Supplements Product Offered

13.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 Ceva Sante Animale

13.2.1 Ceva Sante Animale Company Information

13.2.2 Ceva Sante Animale Pet Meds and Supplements Product Offered

13.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ceva Sante Animale Main Business Overview

13.2.5 Ceva Sante Animale Latest Developments

13.3 Bimeda Animal Health

13.3.1 Bimeda Animal Health Company Information

13.3.2 Bimeda Animal Health Pet Meds and Supplements Product Offered

13.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bimeda Animal Health Main Business Overview

13.3.5 Bimeda Animal Health Latest Developments

13.4 Dechra Pharmaceuticals

13.4.1 Dechra Pharmaceuticals Company Information

13.4.2 Dechra Pharmaceuticals Pet Meds and Supplements Product Offered

13.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Dechra Pharmaceuticals Main Business Overview

13.4.5 Dechra Pharmaceuticals Latest Developments

13.5 Zoetis

13.5.1 Zoetis Company Information

13.5.2 Zoetis Pet Meds and Supplements Product Offered

13.5.3 Zoetis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Zoetis Main Business Overview

13.5.5 Zoetis Latest Developments

13.6 Merck

13.6.1 Merck Company Information

13.6.2 Merck Pet Meds and Supplements Product Offered

13.6.3 Merck Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck Main Business Overview

13.6.5 Merck Latest Developments

13.7 Elanco

13.7.1 Elanco Company Information

13.7.2 Elanco Pet Meds and Supplements Product Offered

13.7.3 Elanco Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Elanco Main Business Overview

13.7.5 Elanco Latest Developments

13.8 Bayer

13.8.1 Bayer Company Information

13.8.2 Bayer Pet Meds and Supplements Product Offered

13.8.3 Bayer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bayer Main Business Overview

13.8.5 Bayer Latest Developments

13.9 Boehringer

13.9.1 Boehringer Company Information

13.9.2 Boehringer Pet Meds and Supplements Product Offered

13.9.3 Boehringer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Boehringer Main Business Overview

13.9.5 Boehringer Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis Pet Meds and Supplements Product Offered

13.10.3 Novartis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 Virbac

13.11.1 Virbac Company Information

13.11.2 Virbac Pet Meds and Supplements Product Offered

13.11.3 Virbac Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Virbac Main Business Overview

13.11.5 Virbac Latest Developments

13.12 Ceva

13.12.1 Ceva Company Information

13.12.2 Ceva Pet Meds and Supplements Product Offered

13.12.3 Ceva Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Ceva Main Business Overview

13.12.5 Ceva Latest Developments

13.13 Vetoquinol

13.13.1 Vetoquinol Company Information

13.13.2 Vetoquinol Pet Meds and Supplements Product Offered

13.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Vetoquinol Main Business Overview

13.13.5 Vetoquinol Latest Developments

13.14 Nexvet

13.14.1 Nexvet Company Information

13.14.2 Nexvet Pet Meds and Supplements Product Offered

13.14.3 Nexvet Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Nexvet Main Business Overview

13.14.5 Nexvet Latest Developments

13.15 Aratana Therapeutics

13.15.1 Aratana Therapeutics Company Information

13.15.2 Aratana Therapeutics Pet Meds and Supplements Product Offered

13.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Aratana Therapeutics Main Business Overview

13.15.5 Aratana Therapeutics Latest Developments

13.16 Kindred Biosciences

13.16.1 Kindred Biosciences Company Information

13.16.2 Kindred Biosciences Pet Meds and Supplements Product Offered

13.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Kindred Biosciences Main Business Overview

13.16.5 Kindred Biosciences Latest Developments

13.17 Ambrx

13.17.1 Ambrx Company Information

13.17.2 Ambrx Pet Meds and Supplements Product Offered

13.17.3 Ambrx Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Ambrx Main Business Overview

13.17.5 Ambrx Latest Developments

13.18 Entest Biomedical

13.18.1 Entest Biomedical Company Information

13.18.2 Entest Biomedical Pet Meds and Supplements Product Offered

13.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Entest Biomedical Main Business Overview

13.18.5 Entest Biomedical Latest Developments

13.19 Taconic Biosciences

13.19.1 Taconic Biosciences Company Information

13.19.2 Taconic Biosciences Pet Meds and Supplements Product Offered

13.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Taconic Biosciences Main Business Overview

13.19.5 Taconic Biosciences Latest Developments

13.20 Dechra Veterinary Products

13.20.1 Dechra Veterinary Products Company Information

13.20.2 Dechra Veterinary Products Pet Meds and Supplements Product Offered

13.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Dechra Veterinary Products Main Business Overview

13.20.5 Dechra Veterinary Products Latest Developments

13.21 Ouro Fino Saude

13.21.1 Ouro Fino Saude Company Information

13.21.2 Ouro Fino Saude Pet Meds and Supplements Product Offered

13.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Ouro Fino Saude Main Business Overview

13.21.5 Ouro Fino Saude Latest Developments

13.22 Norbrook

13.22.1 Norbrook Company Information

13.22.2 Norbrook Pet Meds and Supplements Product Offered

13.22.3 Norbrook Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Norbrook Main Business Overview

13.22.5 Norbrook Latest Developments

13.23 Frontline

13.23.1 Frontline Company Information

13.23.2 Frontline Pet Meds and Supplements Product Offered

13.23.3 Frontline Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Frontline Main Business Overview

13.23.5 Frontline Latest Developments

13.24 Zesty Paws

13.24.1 Zesty Paws Company Information

13.24.2 Zesty Paws Pet Meds and Supplements Product Offered

13.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Zesty Paws Main Business Overview

13.24.5 Zesty Paws Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pet Meds and Supplements Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pet Meds and Supplements Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of External Use

Table 4. Major Players of Oral Use

Table 5. Global Pet Meds and Supplements Sales by Type (2017-2022) & (Units)

Table 6. Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)

Table 7. Global Pet Meds and Supplements Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pet Meds and Supplements Revenue Market Share by Type (2017-2022)

Table 9. Global Pet Meds and Supplements Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Pet Meds and Supplements Sales by Application (2017-2022) & (Units)

Table 11. Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)

Table 12. Global Pet Meds and Supplements Revenue by Application (2017-2022)

Table 13. Global Pet Meds and Supplements Revenue Market Share by Application (2017-2022)

Table 14. Global Pet Meds and Supplements Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Pet Meds and Supplements Sales by Company (2020-2022) & (Units)

Table 16. Global Pet Meds and Supplements Sales Market Share by Company (2020-2022)

Table 17. Global Pet Meds and Supplements Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pet Meds and Supplements Revenue Market Share by Company (2020-2022)

Table 19. Global Pet Meds and Supplements Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Pet Meds and Supplements Producing Area Distribution and Sales Area

Table 21. Players Pet Meds and Supplements Products Offered

Table 22. Pet Meds and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pet Meds and Supplements Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Pet Meds and Supplements Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pet Meds and Supplements Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pet Meds and Supplements Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pet Meds and Supplements Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Pet Meds and Supplements Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pet Meds and Supplements Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pet Meds and Supplements Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pet Meds and Supplements Sales by Country (2017-2022) & (Units)

Table 34. Americas Pet Meds and Supplements Sales Market Share by Country (2017-2022)

Table 35. Americas Pet Meds and Supplements Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pet Meds and Supplements Revenue Market Share by Country (2017-2022)

Table 37. Americas Pet Meds and Supplements Sales by Type (2017-2022) & (Units)

Table 38. Americas Pet Meds and Supplements Sales Market Share by Type (2017-2022)

Table 39. Americas Pet Meds and Supplements Sales by Application (2017-2022) & (Units)

Table 40. Americas Pet Meds and Supplements Sales Market Share by Application (2017-2022)

Table 41. APAC Pet Meds and Supplements Sales by Region (2017-2022) & (Units)

Table 42. APAC Pet Meds and Supplements Sales Market Share by Region (2017-2022)

Table 43. APAC Pet Meds and Supplements Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pet Meds and Supplements Revenue Market Share by Region (2017-2022)

Table 45. APAC Pet Meds and Supplements Sales by Type (2017-2022) & (Units)

Table 46. APAC Pet Meds and Supplements Sales Market Share by Type (2017-2022)

Table 47. APAC Pet Meds and Supplements Sales by Application (2017-2022) & (Units)

Table 48. APAC Pet Meds and Supplements Sales Market Share by Application (2017-2022)

Table 49. Europe Pet Meds and Supplements Sales by Country (2017-2022) & (Units)

Table 50. Europe Pet Meds and Supplements Sales Market Share by Country (2017-2022)

Table 51. Europe Pet Meds and Supplements Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pet Meds and Supplements Revenue Market Share by Country (2017-2022)

Table 53. Europe Pet Meds and Supplements Sales by Type (2017-2022) & (Units)

Table 54. Europe Pet Meds and Supplements Sales Market Share by Type (2017-2022)

Table 55. Europe Pet Meds and Supplements Sales by Application (2017-2022) & (Units)

Table 56. Europe Pet Meds and Supplements Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pet Meds and Supplements Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pet Meds and Supplements Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pet Meds and Supplements Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Pet Meds and Supplements Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pet Meds and Supplements Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Pet Meds and Supplements Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pet Meds and Supplements

Table 66. Key Market Challenges & Risks of Pet Meds and Supplements

Table 67. Key Industry Trends of Pet Meds and Supplements

Table 68. Pet Meds and Supplements Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pet Meds and Supplements Distributors List

Table 71. Pet Meds and Supplements Customer List

Table 72. Global Pet Meds and Supplements Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Pet Meds and Supplements Sales Market Forecast by Region

Table 74. Global Pet Meds and Supplements Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pet Meds and Supplements Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pet Meds and Supplements Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Pet Meds and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pet Meds and Supplements Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Pet Meds and Supplements Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pet Meds and Supplements Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Pet Meds and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pet Meds and Supplements Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Pet Meds and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pet Meds and Supplements Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Pet Meds and Supplements Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pet Meds and Supplements Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pet Meds and Supplements Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pet Meds and Supplements Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Pet Meds and Supplements Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pet Meds and Supplements Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pet Meds and Supplements Revenue Market Share Forecast by Application (2023-2028)

Table 92. Boehringer Ingelheim Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 93. Boehringer Ingelheim Pet Meds and Supplements Product Offered

Table 94. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Boehringer Ingelheim Main Business

Table 96. Boehringer Ingelheim Latest Developments

Table 97. Ceva Sante Animale Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 98. Ceva Sante Animale Pet Meds and Supplements Product Offered

Table 99. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Ceva Sante Animale Main Business

Table 101. Ceva Sante Animale Latest Developments

Table 102. Bimeda Animal Health Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 103. Bimeda Animal Health Pet Meds and Supplements Product Offered

Table 104. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Bimeda Animal Health Main Business

Table 106. Bimeda Animal Health Latest Developments

Table 107. Dechra Pharmaceuticals Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 108. Dechra Pharmaceuticals Pet Meds and Supplements Product Offered

Table 109. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Dechra Pharmaceuticals Main Business

Table 111. Dechra Pharmaceuticals Latest Developments

Table 112. Zoetis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 113. Zoetis Pet Meds and Supplements Product Offered

Table 114. Zoetis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Zoetis Main Business

Table 116. Zoetis Latest Developments

Table 117. Merck Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 118. Merck Pet Meds and Supplements Product Offered

Table 119. Merck Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Merck Main Business

Table 121. Merck Latest Developments

Table 122. Elanco Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 123. Elanco Pet Meds and Supplements Product Offered

Table 124. Elanco Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Elanco Main Business

Table 126. Elanco Latest Developments

Table 127. Bayer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 128. Bayer Pet Meds and Supplements Product Offered

Table 129. Bayer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Bayer Main Business

Table 131. Bayer Latest Developments

Table 132. Boehringer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 133. Boehringer Pet Meds and Supplements Product Offered

Table 134. Boehringer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Boehringer Main Business

Table 136. Boehringer Latest Developments

Table 137. Novartis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 138. Novartis Pet Meds and Supplements Product Offered

Table 139. Novartis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Novartis Main Business

Table 141. Novartis Latest Developments

Table 142. Virbac Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 143. Virbac Pet Meds and Supplements Product Offered

Table 144. Virbac Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Virbac Main Business

Table 146. Virbac Latest Developments

Table 147. Ceva Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 148. Ceva Pet Meds and Supplements Product Offered

Table 149. Ceva Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Ceva Main Business

Table 151. Ceva Latest Developments

Table 152. Vetoquinol Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 153. Vetoquinol Pet Meds and Supplements Product Offered

Table 154. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Vetoquinol Main Business

Table 156. Vetoquinol Latest Developments

Table 157. Nexvet Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 158. Nexvet Pet Meds and Supplements Product Offered

Table 159. Nexvet Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Nexvet Main Business

Table 161. Nexvet Latest Developments

Table 162. Aratana Therapeutics Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 163. Aratana Therapeutics Pet Meds and Supplements Product Offered

Table 164. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Aratana Therapeutics Main Business

Table 166. Aratana Therapeutics Latest Developments

Table 167. Kindred Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 168. Kindred Biosciences Pet Meds and Supplements Product Offered

Table 169. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Kindred Biosciences Main Business

Table 171. Kindred Biosciences Latest Developments

Table 172. Ambrx Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 173. Ambrx Pet Meds and Supplements Product Offered

Table 174. Ambrx Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Ambrx Main Business

Table 176. Ambrx Latest Developments

Table 177. Entest Biomedical Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 178. Entest Biomedical Pet Meds and Supplements Product Offered

Table 179. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Entest Biomedical Main Business

Table 181. Entest Biomedical Latest Developments

Table 182. Taconic Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 183. Taconic Biosciences Pet Meds and Supplements Product Offered

Table 184. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Taconic Biosciences Main Business

Table 186. Taconic Biosciences Latest Developments

Table 187. Dechra Veterinary Products Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 188. Dechra Veterinary Products Pet Meds and Supplements Product Offered

Table 189. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 190. Dechra Veterinary Products Main Business

Table 191. Dechra Veterinary Products Latest Developments

Table 192. Ouro Fino Saude Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 193. Ouro Fino Saude Pet Meds and Supplements Product Offered

Table 194. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 195. Ouro Fino Saude Main Business

Table 196. Ouro Fino Saude Latest Developments

Table 197. Norbrook Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 198. Norbrook Pet Meds and Supplements Product Offered

Table 199. Norbrook Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 200. Norbrook Main Business

Table 201. Norbrook Latest Developments

Table 202. Frontline Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 203. Frontline Pet Meds and Supplements Product Offered

Table 204. Frontline Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 205. Frontline Main Business

Table 206. Frontline Latest Developments

Table 207. Zesty Paws Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors

Table 208. Zesty Paws Pet Meds and Supplements Product Offered

Table 209. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 210. Zesty Paws Main Business

Table 211. Zesty Paws Latest Developments

List of Figures

Figure 1. Picture of Pet Meds and Supplements

Figure 2. Pet Meds and Supplements Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pet Meds and Supplements Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Pet Meds and Supplements Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pet Meds and Supplements Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of External Use

Figure 10. Product Picture of Oral Use

Figure 11. Global Pet Meds and Supplements Sales Market Share by Type in 2021

Figure 12. Global Pet Meds and Supplements Revenue Market Share by Type (2017-2022)

Figure 13. Pet Meds and Supplements Consumed in Dogs

Figure 14. Global Pet Meds and Supplements Market: Dogs (2017-2022) & (Units)

Figure 15. Pet Meds and Supplements Consumed in Cats

Figure 16. Global Pet Meds and Supplements Market: Cats (2017-2022) & (Units)

Figure 17. Pet Meds and Supplements Consumed in Rabbit

Figure 18. Global Pet Meds and Supplements Market: Rabbit (2017-2022) & (Units)

Figure 19. Pet Meds and Supplements Consumed in Bird

Figure 20. Global Pet Meds and Supplements Market: Bird (2017-2022) & (Units)

Figure 21. Pet Meds and Supplements Consumed in Other

Figure 22. Global Pet Meds and Supplements Market: Other (2017-2022) & (Units)

Figure 23. Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)

Figure 24. Global Pet Meds and Supplements Revenue Market Share by Application in 2021

Figure 25. Pet Meds and Supplements Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Pet Meds and Supplements Revenue Market Share by Company in 2021

Figure 27. Global Pet Meds and Supplements Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Pet Meds and Supplements Revenue Market Share by Geographic Region in 2021

Figure 29. Global Pet Meds and Supplements Sales Market Share by Region (2017-2022)

Figure 30. Global Pet Meds and Supplements Revenue Market Share by Country/Region in 2021

Figure 31. Americas Pet Meds and Supplements Sales 2017-2022 (Units)

Figure 32. Americas Pet Meds and Supplements Revenue 2017-2022 ($ Millions)

Figure 33. APAC Pet Meds and Supplements Sales 2017-2022 (Units)

Figure 34. APAC Pet Meds and Supplements Revenue 2017-2022 ($ Millions)

Figure 35. Europe Pet Meds and Supplements Sales 2017-2022 (Units)

Figure 36. Europe Pet Meds and Supplements Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Pet Meds and Supplements Sales 2017-2022 (Units)

Figure 38. Middle East & Africa Pet Meds and Supplements Revenue 2017-2022 ($ Millions)

Figure 39. Americas Pet Meds and Supplements Sales Market Share by Country in 2021

Figure 40. Americas Pet Meds and Supplements Revenue Market Share by Country in 2021

Figure 41. United States Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Pet Meds and Supplements Sales Market Share by Region in 2021

Figure 46. APAC Pet Meds and Supplements Revenue Market Share by Regions in 2021

Figure 47. China Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Pet Meds and Supplements Sales Market Share by Country in 2021

Figure 54. Europe Pet Meds and Supplements Revenue Market Share by Country in 2021

Figure 55. Germany Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country in 2021

Figure 62. Egypt Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Pet Meds and Supplements in 2021

Figure 68. Manufacturing Process Analysis of Pet Meds and Supplements

Figure 69. Industry Chain Structure of Pet Meds and Supplements

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390